Connection

James Ballenger to Depressive Disorder

Back to Details
This is a "connection" page, showing publications James Ballenger has written about Depressive Disorder.
James Ballenger
Connection Strength
2.125
Depressive Disorder
  1. Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001; 62 Suppl 13:47-55.
    View in: PubMed
    Score: 0.135
  2. Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry. 2001; 62 Suppl 8:24-7.
    View in: PubMed
    Score: 0.135
  3. Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry. 2001; 62 Suppl 8:48-51.
    View in: PubMed
    Score: 0.135
  4. Consensus statement on depression, anxiety, and oncology. J Clin Psychiatry. 2001; 62 Suppl 8:64-7.
    View in: PubMed
    Score: 0.135
  5. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry. 2000 Nov 15; 48(10):962-70.
    View in: PubMed
    Score: 0.134
  6. Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1999; 60 Suppl 7:54-61.
    View in: PubMed
    Score: 0.117
  7. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 1999; 60 Suppl 22:29-34.
    View in: PubMed
    Score: 0.117
  8. Comorbidity of panic and depression: implications for clinical management. Int Clin Psychopharmacol. 1998 Apr; 13 Suppl 4:S13-7.
    View in: PubMed
    Score: 0.111
  9. Clinical evaluation of venlafaxine. J Clin Psychopharmacol. 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S.
    View in: PubMed
    Score: 0.098
  10. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7.
    View in: PubMed
    Score: 0.094
  11. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiatry. 1993 Jun; 54(6):224-8.
    View in: PubMed
    Score: 0.080
  12. Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. J Psychiatr Res. 1993 Apr-Jun; 27(2):161-72.
    View in: PubMed
    Score: 0.079
  13. Tricyclic antidepressant triggers mania in patient with organic affective disorder. J Clin Psychiatry. 1992 Oct; 53(10):377-8.
    View in: PubMed
    Score: 0.076
  14. Effect of alprazolam on depression in panic disorder. J Clin Psychopharmacol. 1991 Apr; 11(2):145-6.
    View in: PubMed
    Score: 0.069
  15. Rapid response of patients simultaneously treated with lithium and nortriptyline. J Clin Psychiatry. 1990 Mar; 51(3):124-5.
    View in: PubMed
    Score: 0.064
  16. Depression in patients receiving lorazepam for panic. Am J Psychiatry. 1989 Sep; 146(9):1230-1.
    View in: PubMed
    Score: 0.061
  17. Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment. J Clin Psychiatry. 1989 Sep; 50(9):356-7.
    View in: PubMed
    Score: 0.061
  18. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacol Bull. 1989; 25(1):68-70.
    View in: PubMed
    Score: 0.059
  19. CSF somatostatin in affective illness and normal volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(4):393-400.
    View in: PubMed
    Score: 0.044
  20. Tricyclic antidepressant use in a patient with bundle branch blocks and ventricular ectopy. J Clin Psychiatry. 1984 Aug; 45(8):353-5.
    View in: PubMed
    Score: 0.043
  21. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001; 62 Suppl 11:53-8.
    View in: PubMed
    Score: 0.034
  22. Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry. 1995 Feb; 56(2):77-80.
    View in: PubMed
    Score: 0.022
  23. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8.
    View in: PubMed
    Score: 0.020
  24. Early family experiences of women with bulimia and depression. Arch Psychiatr Nurs. 1990 Feb; 4(1):43-52.
    View in: PubMed
    Score: 0.016
  25. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord. 1989 Jan-Feb; 16(1):49-58.
    View in: PubMed
    Score: 0.015
  26. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry. 1987 May; 144(5):664-5.
    View in: PubMed
    Score: 0.013
  27. The effects of lithium on neuroendocrine function in affectively ill patients. Acta Psychiatr Scand. 1986 May; 73(5):524-8.
    View in: PubMed
    Score: 0.012
  28. Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness. Arch Gen Psychiatry. 1986 Apr; 43(4):392-6.
    View in: PubMed
    Score: 0.012
  29. Neuroendocrine effects of the dopamine agonist piribedil in depressed patients. Clin Neuropharmacol. 1986; 9(5):448-55.
    View in: PubMed
    Score: 0.012
  30. The dexamethasone suppression test in agoraphobia. J Clin Psychopharmacol. 1985 Apr; 5(2):100-2.
    View in: PubMed
    Score: 0.011
  31. Effects of carbamazepine on cerebrospinal fluid somatostatin. Psychopharmacology (Berl). 1985; 85(2):210-3.
    View in: PubMed
    Score: 0.011
  32. Tetrahydrobiopterin levels in cerebrospinal fluid of affectively ill patients. Lancet. 1983 Jul 02; 2(8340):55-6.
    View in: PubMed
    Score: 0.010
  33. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry. 1983 Jun; 40(6):673-6.
    View in: PubMed
    Score: 0.010
  34. CSF somatostatin in affective illness. Arch Gen Psychiatry. 1983 Apr; 40(4):409-12.
    View in: PubMed
    Score: 0.010
  35. Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):263-71.
    View in: PubMed
    Score: 0.010
  36. Generalized anxiety disorder: comorbidity, comparative biology and treatment. Int J Neuropsychopharmacol. 2002 Dec; 5(4):315-25.
    View in: PubMed
    Score: 0.010
  37. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter". Arch Gen Psychiatry. 1981 Dec; 38(12):1315-7.
    View in: PubMed
    Score: 0.009
  38. Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response. Psychiatry Res. 1981 Aug; 5(1):59-66.
    View in: PubMed
    Score: 0.009
  39. Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers. Psychiatry Res. 1981 Aug; 5(1):87-93.
    View in: PubMed
    Score: 0.009
  40. Infrequent panic attacks: psychiatric comorbidity, personality characteristics and functional disability. J Psychiatr Res. 1995 Mar-Apr; 29(2):121-31.
    View in: PubMed
    Score: 0.006
  41. Eating disorders and social phobia. Arch Gen Psychiatry. 1993 Jan; 50(1):70.
    View in: PubMed
    Score: 0.005
  42. Cocaine abuse among schizophrenic patients. Am J Psychiatry. 1990 Sep; 147(9):1164-7.
    View in: PubMed
    Score: 0.004
  43. Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatry. 1982 Sep; 17(9):1037-45.
    View in: PubMed
    Score: 0.002
  44. Endorphins in the cerebrospinal fluid of psychiatric patients. Ann N Y Acad Sci. 1982; 398:399-412.
    View in: PubMed
    Score: 0.002
  45. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am J Psychiatry. 1981 Nov; 138(11):1457-62.
    View in: PubMed
    Score: 0.002
  46. Measurement of endorphins in CSF. Relationship to psychiatric diagnosis. Mod Probl Pharmacopsychiatry. 1981; 17:246-62.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.